Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholestyramine versus low-fat diet for bile acid malabsorption after pelvic cancer treatment
2019-004600-35Phase 4Terminated
- Sponsor
- Aarhus University Hospital
- Start
- Dec 2019
- Modality
- Small Molecules, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cholestyramine in bile acid diarrhea (BAD) and Bile acid diarrhea (BAD) (3 arms), sponsored by Aarhus University Hospital. Started Dec 2019; status: terminated.
02
Drugs
cholestyramine
03
Conditions
bile acid diarrhea (BAD)Bile acid diarrhea (BAD)
Beyond the preview
Go deeper on 2019-004600-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004600-35.